| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.5 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |